Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2409021 vs Sitagliptin in Type 2 Diabetes Mellitus
NCT02111096Phase 2Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2014
- Primary completion
- Sep 2015
- Countries
- 4
01
Overview
A Phase 2 trial of adomeglivant in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Apr 2014; status: terminated.
02
Drugs
adomeglivant
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02111096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111096.